Filing Details
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) filed a Form 8-K with the Securities and Exchange Commission on July 06, 2026, disclosing a material event.
8k filedNASDAQ:CRBP
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Reports Material Event to SEC
Filing Details Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) filed a Form 8-K with the Securities and Exchange Commission on July 06, 2026, disclosing a material event.…
Market Context
Corbus Pharmaceuticals Holdings, Inc.'s stock currently trades at $9.00 with a market capitalization of $121.6M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Corbus Pharmaceuticals Holdings, Inc.'s stock.
All SEC filings for Corbus Pharmaceuticals Holdings, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CRBP Stock Page
Frequently Asked Questions
Where can I read CRBP's SEC filings?
Browse all filings on our CRBP SEC filings page.
What types of SEC filings does Corbus Pharmaceuticals Holdings, Inc. file?
Public companies like Corbus Pharmaceuticals Holdings, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.